Fat transforms ascorbic acid from inhibiting to promoting acid-catalysed N-nitrosation

Background: The major potential site of acid nitrosation is the proximal stomach, an anatomical site prone to a rising incidence of metaplasia and adenocarcinoma. Nitrite, a pre-carcinogen present in saliva, can be converted to nitrosating species and N-nitroso compounds by acidification at low gastric pH in the presence of thiocyanate. Aims: To assess the effect of lipid and ascorbic acid on the nitrosative chemistry under conditions simulating the human proximal stomach. Methods: The nitrosative chemistry was modelled in vitro by measuring the nitrosation of four secondary amines under conditions simulating the proximal stomach. The N-nitrosamines formed were measured by gas chromatography–ion-trap tandem mass spectrometry, while nitric oxide and oxygen levels were measured amperometrically. Results: In absence of lipid, nitrosative stress was inhibited by ascorbic acid through conversion of nitrosating species to nitric oxide. Addition of ascorbic acid reduced the amount of N-nitrosodimethylamine formed by fivefold, N-nitrosomorpholine by >1000-fold, and totally prevented the formation of N-nitrosodiethylamine and N-nitrosopiperidine. In contrast, when 10% lipid was present, ascorbic acid increased the amount of N-nitrosodimethylamine, N-nitrosodiethylamine and N-nitrosopiperidine formed by approximately 8-, 60- and 140-fold, respectively, compared with absence of ascorbic acid. Conclusion: The presence of lipid converts ascorbic acid from inhibiting to promoting acid nitrosation. This may be explained by nitric oxide, formed by ascorbic acid in the aqueous phase, being able to regenerate nitrosating species by reacting with oxygen in the lipid phase.

[1]  L J Schouten,et al.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. , 2000, International journal of epidemiology.

[2]  S. Moncada,et al.  The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. , 1995, Biochemical and biophysical research communications.

[3]  D. Wink,et al.  Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. , 1998, Free radical biology & medicine.

[4]  T. Cebula,et al.  DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. , 1991, Science.

[5]  D. Stanbury,et al.  Autoxidation of NO in aqueous solution , 1993 .

[6]  D. Wink,et al.  Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction. , 1993, Chemical Research in Toxicology.

[7]  K. McColl,et al.  Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia , 2003, Gut.

[8]  C. Schorah,et al.  Measurement of ascorbic acid and dehydroascorbic acid in gastric juice by HPLC. , 1987, Biomedical chromatography : BMC.

[9]  K. McColl,et al.  Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. , 2001, Gastroenterology.

[10]  S. Tannenbaum,et al.  The effect of nitrate intake on nitrite formation in human saliva. , 1976, Food and cosmetics toxicology.

[11]  L. Sharp,et al.  Oesophageal and gastric cancer in Scotland 1960-90. , 1995, British Journal of Cancer.

[12]  P. A. van den Brandt,et al.  The reproducibility of the conversion of nitrate to nitrite in human saliva after a nitrate load. , 1988, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[13]  K. McColl.  Cancer of the gastric cardia. , 2006, Best practice & research. Clinical gastroenterology.

[14]  P. Vallance,et al.  Measurement of nitrite and nitrate levels in plasma and urine--what does this measure tell us about the activity of the endogenous nitric oxide system? , 1998, Current opinion in nephrology and hypertension.

[15]  C. Colton,et al.  Reactive Oxygen Species in Biological Systems , 2013, Springer US.

[16]  Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. , 2000, Cancer research.

[17]  C. Mowat,et al.  Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. , 1999, Gastroenterology.

[18]  Xiaoping Liu,et al.  Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Tannenbaum,et al.  Metabolic fate of an oral dose of 15N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid. , 1983, Cancer research.

[20]  D. Kokkinakis,et al.  The significance of DNA damage, its repair and cell proliferation during carcinogen treatment in the initiation of pancreatic cancer in the hamster model. , 1993, Cancer research.

[21]  S. Tannenbaum,et al.  Factors influencing the rate of formation of nitrosomorpholine from morpholine and nitrite: acceleration by thiocyanate and other anions. , 1973, Journal of agricultural and food chemistry.

[22]  S. Walker,et al.  Effect of thiocyanate on nitrosation of amines , 1974, Nature.

[23]  Y. Sasaki,et al.  Detection of in vivo genotoxicity of endogenously formed N-nitroso compounds and suppression by ascorbic acid, teas and fruit juices. , 2003, Mutation research.

[24]  D. Wink,et al.  A discussion of mechanisms of NO genotoxicity: implication of inhibition of DNA repair proteins. , 1997, Reviews of physiology, biochemistry and pharmacology.

[25]  H. Bartsch,et al.  Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention. , 1988, Mutation research.

[26]  James B. Mitchell,et al.  Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. , 1996, Current topics in cellular regulation.

[27]  B. C. Challis,et al.  Rapid formation of N-nitrosamines from nitrogen oxides under neutral and alkaline conditions. , 1978, IARC scientific publications.

[28]  M. Hill.  Nitrosamines : toxicology and microbiology , 1988 .

[29]  A. Axon,et al.  Ascorbic acid in the human stomach. , 1989, Gastroenterology.

[30]  S. Vollset,et al.  Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status , 2007, Gut.

[31]  F. Corrales,et al.  Nitric oxide inactivates rat hepatic methionine adenosyltransferase in vivo by S‐nitrosylation , 1998, Hepatology.

[32]  P. Shubik,et al.  Ascorbate-Nitrite Reaction: Possible Means of Blocking the Formation of Carcinogenic N-Nitroso Compounds , 1972, Science.

[33]  D. Roe,et al.  Influence of ascorbic acid dose on N-nitrosoproline formation in humans. , 1987, Carcinogenesis.

[34]  S. Mirvish,et al.  Inhibition by vitamins C and E of in vivo nitrosation and vitamin C occurrence in the stomach , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[35]  K. Fischermann,et al.  Diagnostic value of the augmented histamine test in cancer of the upper part of the stomach. , 1969, Scandinavian journal of gastroenterology.

[36]  K. Reimers,et al.  Dosing time with ascorbic acid and nitrate, gum and tobacco chewing, fasting, and other factors affecting N-nitrosoproline formation in healthy subjects taking proline with a standard meal. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  O. Bøckman,et al.  Nitrate and nitrite concentrations in human saliva: variations with salivary flow-rate. , 1989, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[38]  J. Primrose,et al.  Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis. , 1991, The American journal of clinical nutrition.

[39]  J. Pérez‐Juste,et al.  Comparative study of nitroso group transfer in colloidal aggregates: micelles, vesicles and microemulsions , 2003 .

[40]  S. Tannenbaum,et al.  DNA damage and mutation in human cells exposed to nitric oxide in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Williams,et al.  N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. , 1996, Pharmacology & therapeutics.

[42]  S. Mirvish.  BLOCKING THE FORMATION OF N‐NITROSO COMPOUNDS WITH ASCORBIC ACID IN VITRO AND IN VIVO * , 1975, Annals of the New York Academy of Sciences.

[43]  M. Hobsley,et al.  Thiocyanate as a marker of saliva in gastric juice? , 1980, Gut.

[44]  C. McConkey,et al.  Continuing rising trend in oesophageal adenocarcinoma , 2002, International journal of cancer.

[45]  D. Wink,et al.  Autoxidation kinetics of aqueous nitric oxide , 1993, FEBS letters.

[46]  C. A. Bunton,et al.  Oxidation of Ascorbic Acid and Similar Reductones by Nitrous Acid , 1959, Nature.

[47]  S. Tannenbaum,et al.  Inhibition of nitrosamine formation by ascorbic acid. , 1991, The American journal of clinical nutrition.

[48]  S. Kyrtopoulos,et al.  The chemistry of nitroso-compounds. Part 11. Nitrosation of amines by the two-phase interaction of amines in solution with gaseous oxides of nitrogen , 1979 .

[49]  S. Cohen,et al.  Liver and forestomach tumors and other forestomach lesions in rats treated with morpholine and sodium nitrite, with and without sodium ascorbate. , 1983, Journal of the National Cancer Institute.

[50]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[51]  K. McColl,et al.  Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. , 2002, Gastroenterology.